Loss of β cells leads to diabetes. α cells are refractory to spontaneous conversion to β cells, but a small percentage are reprogrammed to β cells with acute β cell loss. β cell heterogeneity and identification of β cell subpopulations and their transcriptomic profiles have been reported. However, α cell subpopulations in the human islet have not been clearly defined yet. Moreover, whether specific human α cell subpopulations can potentially evolve into β cells is unknown. Here, we integrated scRNA- and snRNA-seq data of human islets from 3 adult healthy donors to determine α cell subpopulations and their transcriptomic profiles. We extracted the α cell cluster (7,535 cells) and using Louvain resolution 0.8, we identified 5 subclusters: 1) α cells (GCGhigh/TTRhigh/PTPRThigh); 2) αβ-Transition-1 (αβ-Tr1) cells; 3) αβ-Tr2 cells; 4) αβ1 cells (GCGhigh/INSlow/IAPPlow); and 5) αβ2 cells (GCGlow/INShigh/IAPPhigh). To investigate the transcriptomics connectivity among clusters, we performed RNA velocity and Partition-based Graph Abstraction (PAGA) analyses. PAGA showed that αβ-Tr1 cells (15.3% of cells) are the root subcluster from where α cells and αβ-Tr2 cells are formed, suggesting a precursor nature. αβ-Tr2 cells are the origin of αβ1 and αβ2 cells. We next projected this finding into the pseudotime algorithm and analyzed gene expression gradients in the trajectories. Interestingly, the αβ-Tr1/αβ-Tr2/αβ2 cells trajectory showed a gradual increase in the expression of β cell genes (INS, ZNF385D, CASR, MAFA) while decreasing expression of ribosomal genes, GCG and MALAT1. Single cell pathway analysis with escape package showed that αβ-Tr1 cells are enriched in ribosome and translation gene pathways and that αβ-Tr2 cells are enriched in transdifferentiation genes INSM1, PDX1 and SMAD3. In summary, these studies identified 5 α cell subpopulations with different transcriptomic profiles and highlight the potential plasticity of αβ-Tr cells to generate αβ cells.

Disclosure

R.Kang: None. J.Lee: None. A.Garcia-ocana: Consultant; Sun Pharmaceutical Industries Ltd. G.Lu: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.